ECONSALUT

Critical comments on health economics and policy

22 de maig 2013

Death, taxes and fiscal deficit

›
Benjamin Franklin said: "The only things certain in life are death and taxes .". If he had lived here, he would have added "...
21 de maig 2013

Healthcare value chain, again

›
Redefining global health-care delivery A remake of what you may already know has been published as article in The Lancet . It could be goo...
13 de maig 2013

Aprés tout (4)

›
An updated release of public health expenditure data has just been published. In 2011, the expenditure on health was 1,330 € per capita , yo...
12 de maig 2013

Wired Health

›
Eric Topol information into action, Wired Health conference Eric Topol: Information into Action at Wired Health from WIRED on FORA.tv ...
10 de maig 2013

Economics of genomics

›
The Economics of Genomic Medicine - Workshop Summary Just imagine for a while that you are concerned about economic implications of genomi...
09 de maig 2013

The right rate

›
International Variations in a Selected Number of Surgical Procedures If you want to be astonished by the huge variation on the rate of sur...
08 de maig 2013

Tackling obesity

›
Integrating Educational, Environmental, and Behavioral Economic Strategies May Improve the  Effectiveness of Obesity Interventions On top ...
30 d’abril 2013

The stratified approach

›
How Health Systems Could Avert 'Triple Fail' Events That Are Harmful, Are Costly,And Result In Poor Patient Satisfaction  While re...
25 d’abril 2013

Aprés tout (3)

›
Publicly funded health expenditure reached 9,162m € in 2012 , although the initial budget was 8,756m €. Therefore, the size of the budget de...
23 d’abril 2013

Against patents

›
The case against patents Some months ago, a WP blog hightlighted a paper by Boldrin and Levine with a straightforward title. Now you can ...
20 d’abril 2013

Full overhaul needed

›
A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe This is exacty what medical devices ...
19 d’abril 2013

Paving the way

›
Default Options In Advance Directives Influence How Patients Set Goals For End-Of-Life Care The end of life is obviously a difficult perio...
05 d’abril 2013

Evergreening (2)

›
The case of Tecfidera deserves a short comment. Imagine a drug for psoriasis, its active ingredient -dimethyl fumarate- modulates the immune...
03 d’abril 2013

Countdown

›
I'm strongly convinced that strong patent rights spur innovation. In the case of genetics and biomarkers, the impact is even stronger. T...
‹
›
Inici
Visualitza la versió per a web
Pere Ibern
Visualitza el meu perfil complet
Amb la tecnologia de Blogger.